Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.99+0.09 (+3.10%)
Close on Nov 16, 2026Market cap $122.78MP/E –Yield –
Scienture profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Scienture's profit margin for the twelve months ending Sep 30, 2025 was -3145.8%. For fiscal 2025 it was -9618.0%, against 6634.7% the year before. The highest annual figure on record is 6634.7% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9618.0% | −16252.7 |
| FY2024 | Dec 31, 2024 | 6634.7% | +7943.0 |
| FY2023 | Dec 31, 2023 | -1308.3% | −1274.5 |
| FY2022 | Dec 31, 2022 | -33.9% | +19.9 |
| FY2021 | Dec 31, 2021 | -53.8% | −38.9 |
| FY2020 | Dec 31, 2020 | -14.8% | −11.0 |
| FY2019 | Dec 31, 2019 | -3.8% | −4.1 |
| FY2018 | Dec 31, 2018 | 0.2% | −9.6 |
| FY2017 | Dec 31, 2017 | 9.9% | +121.1 |
| FY2016 | Dec 31, 2016 | -111.2% | −72.9 |
| FY2015 | Dec 31, 2015 | -38.4% | +96.1 |
| FY2014 | Dec 31, 2014 | -134.5% | +84.3 |
| FY2013 | Dec 31, 2013 | -218.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -821.3% | +12672.1 |
| Q1 FY2026 | Mar 31, 2026 | -6040.4% | −1132.1 |
| Q3 FY2025 | Sep 30, 2025 | -611.4% | +9196.1 |
| Q1 FY2025 | Mar 31, 2025 | -29869.3% | −20802.5 |
| Q4 FY2024 | Dec 31, 2024 | -13493.5% | −12594.8 |
| Q3 FY2024 | Sep 30, 2024 | -4908.3% | −4369.5 |
| Q2 FY2024 | Jun 30, 2024 | -9807.5% | −9670.1 |
| Q4 FY2023 | Dec 31, 2023 | -9066.9% | −9025.9 |
| Q3 FY2023 | Sep 30, 2023 | -898.6% | −874.1 |
| Q2 FY2023 | Jun 30, 2023 | -538.8% | −504.9 |
| Q1 FY2023 | Mar 31, 2023 | -137.4% | −107.6 |
| Q4 FY2022 | Dec 31, 2022 | -41.0% | −8.2 |
| Q3 FY2022 | Sep 30, 2022 | -24.5% | +26.6 |
| Q2 FY2022 | Jun 30, 2022 | -33.9% | +101.9 |
| Q1 FY2022 | Mar 31, 2022 | -29.8% | −8.5 |
| Q4 FY2021 | Dec 31, 2021 | -32.8% | +83.1 |
| Q3 FY2021 | Sep 30, 2021 | -51.0% | −53.2 |
| Q2 FY2021 | Jun 30, 2021 | -135.8% | −127.6 |
| Q1 FY2021 | Mar 31, 2021 | -21.3% | −29.5 |
| Q4 FY2020 | Dec 31, 2020 | -115.9% | −86.7 |
| Q3 FY2020 | Sep 30, 2020 | 2.2% | +1.0 |
| Q2 FY2020 | Jun 30, 2020 | -8.2% | −11.3 |
| Q1 FY2020 | Mar 31, 2020 | 8.2% | −0.1 |
| Q4 FY2019 | Dec 31, 2019 | -29.2% | −14.7 |
| Q3 FY2019 | Sep 30, 2019 | 1.2% | −9.9 |
| Q2 FY2019 | Jun 30, 2019 | 3.0% | +0.6 |
| Q1 FY2019 | Mar 31, 2019 | 8.3% | −1.4 |
| Q4 FY2018 | Dec 31, 2018 | -14.5% | −32.2 |
| Q3 FY2018 | Sep 30, 2018 | 11.1% | +0.8 |
| Q2 FY2018 | Jun 30, 2018 | 2.4% | +3.4 |
| Q1 FY2018 | Mar 31, 2018 | 9.6% | −1.0 |
| Q4 FY2017 | Dec 31, 2017 | 17.7% | +87.2 |
| Q3 FY2017 | Sep 30, 2017 | 10.4% | +148.3 |
| Q2 FY2017 | Jun 30, 2017 | -1.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 10.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -69.4% | – |
| Q3 FY2016 | Sep 30, 2016 | -138.0% | – |
See a number that looks wrong?